AN ACT to amend Tennessee Code Annotated, Title 53 and Title 63, relative to buprenorphine.
- Introduced Jan 26, 2023
- In committee Feb 1, 2023
- Died
- Passed the Senate
- To the governor
- Became law
What it does
The legislature's own summary of the bill, or its official long title.
Opioids - As introduced, prohibits a healthcare provider from prescribing a buprenorphine product unless the patient has first signed a copy of an informational document on the risks of buprenorphine use to pregnant women, unborn children, and infants; requires the department of health to make available on its public website the informational document within 90 days of the effective date of the act. - Amends TCA Title 53 and Title 63.
Every action
4 steps, oldest first, as the legislature records them.
- HouseFiled for introduction
- HouseIntro., P1C.
- CommitteeP2C, ref. to Health Committee · House Health Committee
- CommitteeAssigned to s/c Health Subcommittee · House Health Subcommittee
Roll calls
No recorded votes on this bill yet.
Sponsors
The member who introduced it.
- TH Tim HicksR Primary sponsor · District 6
From Tennessee's official records (wapp.capitol.tn.gov), checked Nov 3, 2026. Text links go to the official versions; LegiList does not copy bill text.